Dissolution Solutions Network

News, Stories and Commentary from the Pharma Lab

NIH Asked to fight price gouging by overriding drug patents

Posted on | January 12, 2016 | Comments Off

A group of 50 congressional lawmakers wants the Obama administration to develop guidelines that would require drug makers to license their patents to others in a bid to end “price gouging.”In their letter, they argue that the National Institutes of Health has the ability to issue so-called march-in rights, which refer to overriding a patent. Under federal law, this allows … MORE000801_0401_0009_tsls


Comments are closed.

  • Topics

  • Recent Posts

  • Pages

  • Meta

  • Network Links

    • follow me on Twitter